Correlation Between Protagonist Therapeutics and Stoke Therapeutics
Can any of the company-specific risk be diversified away by investing in both Protagonist Therapeutics and Stoke Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Protagonist Therapeutics and Stoke Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Protagonist Therapeutics and Stoke Therapeutics, you can compare the effects of market volatilities on Protagonist Therapeutics and Stoke Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Protagonist Therapeutics with a short position of Stoke Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Protagonist Therapeutics and Stoke Therapeutics.
Diversification Opportunities for Protagonist Therapeutics and Stoke Therapeutics
0.68 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Protagonist and Stoke is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Protagonist Therapeutics and Stoke Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Stoke Therapeutics and Protagonist Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Protagonist Therapeutics are associated (or correlated) with Stoke Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Stoke Therapeutics has no effect on the direction of Protagonist Therapeutics i.e., Protagonist Therapeutics and Stoke Therapeutics go up and down completely randomly.
Pair Corralation between Protagonist Therapeutics and Stoke Therapeutics
Given the investment horizon of 90 days Protagonist Therapeutics is expected to generate 0.43 times more return on investment than Stoke Therapeutics. However, Protagonist Therapeutics is 2.33 times less risky than Stoke Therapeutics. It trades about -0.26 of its potential returns per unit of risk. Stoke Therapeutics is currently generating about -0.23 per unit of risk. If you would invest 4,060 in Protagonist Therapeutics on October 23, 2024 and sell it today you would lose (378.00) from holding Protagonist Therapeutics or give up 9.31% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Protagonist Therapeutics vs. Stoke Therapeutics
Performance |
| Timeline |
| Protagonist Therapeutics |
| Stoke Therapeutics |
Protagonist Therapeutics and Stoke Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Protagonist Therapeutics and Stoke Therapeutics
The main advantage of trading using opposite Protagonist Therapeutics and Stoke Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Protagonist Therapeutics position performs unexpectedly, Stoke Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Stoke Therapeutics will offset losses from the drop in Stoke Therapeutics' long position.| Protagonist Therapeutics vs. Revolution Medicines | Protagonist Therapeutics vs. Akero Therapeutics | Protagonist Therapeutics vs. Avidity Biosciences | Protagonist Therapeutics vs. Stoke Therapeutics |
| Stoke Therapeutics vs. Adaptimmune Therapeutics Plc | Stoke Therapeutics vs. Black Diamond Therapeutics | Stoke Therapeutics vs. Relay Therapeutics | Stoke Therapeutics vs. Pliant Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |